The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

15 articles for T Yamada


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography.EBI
Yamanouchi Pharmaceutical
Design, synthesis, and properties of des-D-ring interphenylene derivatives of 1α,25-Dihydroxyvitamin DEBI
Kanagawa University
Highly Potent and Oral Macrocyclic Peptides as a HIV-1 Protease Inhibitor: mRNA Display-Derived Hit-to-Lead Optimization.EBI
Shionogi
Structure-activity relationship of N-[2-(dimethylamino)-6-[3-(5-methyl-4-phenyl-1H-imidazol-1-yl)propoxy] phenyl]-N'-pentylurea and analogues. Novel potent inhibitors of acyl-CoA:cholesterol O-acyltransferase with antiatherosclerotic activity.EBI
Eisai
Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities.EBI
University of Arizona
Novel 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2)-curcumin, kojic acid, quercetin, and baicalein conjugates as HIV agents.EBI
Osaka University of Pharmaceutical Sciences
DCN-1 MODULATING COMPOUNDS AND METHODS OF USE THEREOFBDB
Cellarity
HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORSBDB
Merck Patent
Methods to determine KDM1A target engagement and chemoprobes useful thereforBDB
Oryzon Genomics
Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amineBDB
Nektar Therapeutics
Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitorsBDB
Bristol-Myers Squibb
Adenosine receptor agonists, partial agonists, and antagonistsBDB
The United States of America, As Represented By The Secretary, Department of Health and Human Services
Structure-activity relationships and X-ray structures describing the selectivity of aminopyrazole inhibitors for c-Jun N-terminal kinase 3 (JNK3) over p38.BDB
The Scripps Research Institute
2-styrylchromones as novel inhibitors of xanthine oxidase. A structure-activity study.BDB
University of Porto-Rua Anibal Cunha
Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.BDB
University of Occupational and Environmental Health